Trial intelligence / Profile preview

Fenofibrate and Coenzyme Q10 in Type 2 Diabetes

NCT00703482Phase 2Completed

Sponsor
Solvay
Start
May 2003
Primary completion
Sep 2004
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of fenofibrate and coenzyme q10 in diastolic dysfunction, sponsored by Solvay. Started May 2003; status: completed.

02

Drugs

fenofibratecoenzyme q10
03

Conditions

diastolic dysfunction

Beyond the preview

Go deeper on NCT00703482.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00703482.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call